{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:21:19Z","timestamp":1789888879412,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the University of Michigan Medical School Global REACH Program"},{"name":"University of Michigan \u2013 Peking University Health Sciences Center Joint Institute for Clinical and Translational Research"},{"name":"the Tuktawa Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10620-018-5389-5","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T04:26:57Z","timestamp":1543292817000},"page":"708-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China"],"prefix":"10.1007","volume":"64","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"5389_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.4254\/wjh.v7.i11.1450","volume":"7","author":"M Ahmed","year":"2015","unstructured":"Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015;7:1450\u20131459.","journal-title":"World J Hepatol"},{"key":"5389_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jgh.12036","volume":"28","author":"JG Fan","year":"2013","unstructured":"Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28:11\u201317.","journal-title":"J Gastroenterol Hepatol"},{"key":"5389_CR3","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1440-1746.2009.05914.x","volume":"24","author":"CM Leung","year":"2009","unstructured":"Leung CM, Lai LS, Wong WH, et al. Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol. 2009;24:1786\u20131790.","journal-title":"J Gastroenterol Hepatol"},{"key":"5389_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/gastro\/gov047","volume":"4","author":"GB Goh","year":"2016","unstructured":"Goh GB, Kwan C, Lim SY, et al. Perceptions of non-alcoholic fatty liver disease\u2014an Asian community-based study. Gastroenterol Rep (Oxf). 2016;4:131\u2013135.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"5389_CR5","first-page":"4","volume":"1","author":"V Ghevariya","year":"2014","unstructured":"Ghevariya V, Sandar N, Patel K, et al. Knowing what\u2019s out there: awareness of non-alcoholic fatty liver disease. Front Med (Lausanne). 2014;1:4.","journal-title":"Front Med (Lausanne)"},{"key":"5389_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090\u20131101.","journal-title":"N Engl J Med"},{"key":"5389_CR7","unstructured":"The International physical activity questionnaire (IPAQ)\u2014Short Form. Available at: \n                    http:\/\/www.ipaq.ki.se\n                    \n                  . Accessed March 22, 2017."},{"key":"5389_CR8","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1161\/CIRCULATIONAHA.108.833574","volume":"119","author":"Z Yu","year":"2009","unstructured":"Yu Z, Ye X, Wang J, et al. Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation. 2009;119:2969\u20132977.","journal-title":"Circulation"},{"key":"5389_CR9","unstructured":"Criteria of weight for adults. The National Health and Family Planning Commission of the People\u2019s Republic of China. April 18, 2013."},{"key":"5389_CR10","unstructured":"Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). Available at: \n                    http:\/\/www.ipaq.ki.se\/scoring.pdf\n                    \n                  . Accessed Octorber 22, 2017."},{"key":"5389_CR11","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/MCG.0000000000000075","volume":"49","author":"AC Wieland","year":"2015","unstructured":"Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015;49:e6\u2013e10.","journal-title":"J Clin Gastroenterol"},{"key":"5389_CR12","unstructured":"Data in Beijing Municipal Bureau of Statistics and Survey Office of the National Bureau of Statistics in Beijing. Available at: \n                    http:\/\/www.bjstats.gov.cn\n                    \n                  . Accessed April 05, 2018."},{"key":"5389_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.295.15.1793","volume":"295","author":"LL Yan","year":"2006","unstructured":"Yan LL, Liu K, Daviglus ML, et al. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. Jama. 2006;295:1793\u20131800.","journal-title":"Jama"},{"key":"5389_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.socscimed.2007.08.027","volume":"66","author":"T Seeman","year":"2008","unstructured":"Seeman T, Merkin SS, Crimmins E, Koretz B, Charette S, Karlamangla A. Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults: NHANES III (1988\u20131994). Soc Sci Med. 2008;66:72\u201387.","journal-title":"Soc Sci Med"},{"key":"5389_CR15","first-page":"357","volume":"26","author":"Z Dong","year":"2010","unstructured":"Dong Z, Gang LI, Xie J. Prevalent charateristics of common chronic diseases among adults in Beijing. Chin J Public Health. 2010;26:357\u2013358.","journal-title":"Chin J Public Health"},{"key":"5389_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12963-014-0028-7","volume":"12","author":"Y Huang","year":"2014","unstructured":"Huang Y, Gao L, Xie X, Tan SC. Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metr. 2014;12:28.","journal-title":"Popul Health Metr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5389-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T19:15:18Z","timestamp":1574795718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5389-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5389"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5389-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"L Wei receives research funding from Abbvie, BMS, and serves as advisor\/consultant for Abbvie, Ascletis, BMS, Gilead, and MSD. AS Lok receives research funding from BMS, Gilead, and TARGET Pharma, and serves as advisor\/consultant for Gilead, Reseverlogix, Roche, Spring Bank, and Viravaxx. Other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}